Lotus Eye Hospital And Institute Ltd
Lotus Eye Hospital And Institute Ltd (LOTUSEYE) last reported results for the quarter ended Jun 2026, with sales of ₹17.06 crore and net profit of ₹0.61 crore. The stock last traded at ₹114, a market capitalisation of ₹238 crore, on a P/E of 1486. Over the past 52 weeks the stock has ranged between ₹97.6 and ₹153. Figures are as of 6 Oct 2026 and are not real time.
Lotus Eye Hospital And Institute Ltd share price and key metrics
- Current price
- ₹114
- Market cap
- ₹238 cr
- Stock P/E
- 1486
- Book value
- ₹28.9
- ROE
- 0.13%
- ROCE
- 1.41%
- Dividend yield
- 0.00%
- 52w high / low
- 153/97.6
Metrics as of 6 Oct 2026. Not real time.
Track Lotus Eye Hospital And Institute Ltd
Cruxal reads every Lotus Eye Hospital And Institute Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Lotus Eye Hospital And Institute Ltd growth and returns
- 10 Years
- 6%
- 5 Years
- 11%
- 3 Years
- 5%
- TTM
- 14%
- 10 Years
- -1%
- 5 Years
- -44%
- 3 Years
- -73%
- TTM
- -75%
- 10 Years
- 17%
- 5 Years
- 20%
- 3 Years
- 11%
- 1 Year
- -5%
- 10 Years
- 3%
- 5 Years
- 4%
- 3 Years
- 2%
- Last Year
- 0%
Lotus Eye Hospital And Institute Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹17.06 cr, up 26.2% from ₹13.52 cr a year earlier. Net profit was ₹0.61 cr, up 13.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.91 | 12.25 | 11.51 | 13.52 | 13.04 | 13.55 | 13.61 | 17.06 |
| Expenses | 11.76 | 11.46 | 11.68 | 12.04 | 12.27 | 12.89 | 13.13 | 14.11 |
| Operating profit | 1.15 | 0.79 | -0.17 | 1.48 | 0.77 | 0.66 | 0.48 | 2.95 |
| OPM % | 8.91% | 6.45% | -1.48% | 10.95% | 5.90% | 4.87% | 3.53% | 17.29% |
| Other income | 0.27 | 0.22 | 0.52 | 0.19 | 0.27 | 0.24 | 0.47 | 0.21 |
| Interest | 0.08 | 0.13 | 0.09 | 0.12 | 0.12 | 0.29 | 0.33 | 0.51 |
| Depreciation | 1.23 | 1.31 | -0.58 | 0.82 | 0.85 | 0.98 | 1.1 | 1.64 |
| Profit before tax | 0.11 | -0.43 | 0.84 | 0.73 | 0.07 | -0.37 | -0.48 | 1.01 |
| Tax % | 9.09% | -44.19% | 70.24% | 24.66% | -71.43% | -29.73% | -33.33% | 39.60% |
| Net profit | 0.1 | -0.24 | 0.25 | 0.54 | 0.12 | -0.26 | -0.32 | 0.61 |
| EPS (₹) | 0.05 | -0.12 | 0.12 | 0.26 | 0.06 | -0.13 | -0.15 | 0.29 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Lotus Eye Hospital And Institute Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.96 | 38.02 | 38.43 | 40.55 | 32.35 | 38.9 | 47.03 | 48.2 | 49.55 | 53.7 | 57.26 |
| Operating profit | 3.33 | 4.34 | 3.22 | 3.98 | 3.62 | 5.92 | 7.68 | 6.63 | 3.56 | 3.55 | 4.86 |
| OPM % | 9.81% | 11.42% | 8.38% | 9.82% | 11.19% | 15.22% | 16.33% | 13.76% | 7.18% | 6.61% | 8.49% |
| Net profit | 0.44 | 1.75 | 0.71 | 1.06 | 1.57 | 2.98 | 4.08 | 2.91 | 0.74 | 0.08 | 0.15 |
| EPS (₹) | 0.21 | 0.84 | 0.34 | 0.51 | 0.75 | 1.43 | 1.96 | 1.40 | 0.36 | 0.04 | 0.07 |
TTM is the trailing twelve months to the most recent quarter.
Lotus Eye Hospital And Institute Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 | 20.80 |
| Reserves | 29.26 | 29.84 | 29.32 | 30.46 | 31.90 | 33.81 | 36.78 | 38.61 | 39.20 | 39.34 |
| Borrowings | 0.48 | 0.29 | 0.22 | 0.32 | 0.40 | 1.24 | 0.67 | 1.11 | 3.43 | 15.83 |
| Other liabilities | 4.40 | 7.28 | 6.18 | 6.53 | 6.12 | 5.75 | 4.93 | 6.11 | 6.14 | 6.63 |
| Total liabilities | 54.94 | 58.21 | 56.52 | 58.11 | 59.22 | 61.60 | 63.18 | 66.63 | 69.57 | 82.60 |
| Fixed assets | 41.32 | 42.52 | 44.14 | 42.67 | 40.54 | 44.07 | 44.18 | 48.65 | 54.07 | 65.81 |
| CWIP | 0.65 | 0.29 | 0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 | 0.09 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 12.97 | 15.40 | 12.09 | 15.44 | 18.68 | 17.53 | 19.00 | 17.90 | 15.50 | 16.70 |
| Total assets | 54.94 | 58.21 | 56.52 | 58.11 | 59.22 | 61.60 | 63.18 | 66.63 | 69.57 | 82.60 |
As reported by the company. Total assets equal total liabilities by construction.
Lotus Eye Hospital And Institute Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 2.97 | 5.78 | 4.20 | 4.97 | 2.73 | 4.41 | 4.39 | 5.68 | 2.70 | 3.02 |
| Cash from investing | -1.06 | -3.86 | -4.01 | -0.68 | 0.49 | -3.94 | -2.19 | -4.63 | -6.13 | -14.39 |
| Cash from financing | -0.25 | -1.51 | -1.41 | 0.13 | -0.32 | -1.58 | -1.71 | -3.40 | -1.60 | 9.03 |
| Net cash flow | 1.66 | 0.41 | -1.22 | 4.42 | 2.90 | -1.10 | 0.49 | -2.35 | -5.03 | -2.34 |
| Free cash flow | 1.55 | 1.58 | -0.49 | 3.54 | 2.61 | -0.25 | 1.30 | 0.10 | -2.09 | -10.01 |
| CFO / operating profit | 92% | 142% | 134% | 132% | 84% | 89% | 76% | 101% | 94% | 94% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Lotus Eye Hospital And Institute Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 1.19% | 3.63% | 1.66% | 4.67% | 3.92% | 7.91% | 10.25% | 7.07% | 2.99% | 1.41% |
| Debtor days | 7.31 | 10.94 | 7.22 | 5.94 | 8.35 | 5.82 | 9.08 | 9.54 | 9.72 | 8.22 |
| Inventory days | 60.22 | 79.23 | 128.20 | 124.42 | 138.82 | 150.03 | 153.60 | 170.30 | 193.62 | 172.16 |
| Days payable | 87.32 | 129.95 | 167.37 | 170.41 | 220.72 | 231.21 | 173.42 | 183.56 | 169.86 | 146.09 |
| Cash conversion cycle | -19.79 | -39.78 | -31.95 | -40.05 | -73.54 | -75.37 | -10.74 | -3.72 | 33.48 | 34.30 |
| Working capital days | -8.92 | -26.02 | -15.39 | -21.33 | -23.92 | -16.33 | 8.61 | 5.68 | 0.00 | -12.17 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Lotus Eye Hospital And Institute Ltd shareholding pattern
Promoters held 40.14% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.02%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.03% | 40.14% | 40.22% | 40.39% | 40.63% | 40.66% | 40.14% | 40.14% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.01% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.04% | 0.04% | 0.02% | 0.02% | 0.02% | 0.02% | 0.02% |
| Public | 59.97% | 59.82% | 59.73% | 59.57% | 59.33% | 59.31% | 59.85% | 59.85% |
| No. of shareholders | 12,514 | 11,734 | 11,508 | 11,121 | 10,777 | 10,240 | 9,939 | 9,627 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Lotus Eye Hospital And Institute Ltd corporate filings
- Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Closure of Trading WindowInsider Trading / SASTlow impact
- Lotus Eye Hospital and Institute Limited Announces Voting Results of 29th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Lotus Eye Hospital and Institute Limited has successfully concluded its 29th Annual…
Read the full analysis - Lotus Eye Hospital and Institute Limited concludes 29th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Lotus Eye Hospital and Institute Limited has successfully concluded its 29th Annual…
Read the full analysis - Lotus Eye Hospital and Institute Ltd announces newspaper publication for 29th AGM and FY 2025-26 Annual ReportCompany Updatelow impact
Cruxal's analysis: Lotus Eye Hospital and Institute Ltd has fulfilled regulatory requirements under…
Read the full analysis - Lotus Eye Hospital and Institute Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Lotus Eye Hospital and Institute Ltd has filed its Annual Report for the financial year…
Read the full analysis - Lotus Eye Hospital and Institute Limited announces 29th AGM and proposes significant remuneration hike for Managing DirectorAGM/EGMmedium impact
Cruxal's analysis: Lotus Eye Hospital and Institute Limited has scheduled its 29th Annual General Meeting…
Read the full analysis - Lotus Eye Hospital and Institute Ltd launches new optical retail brand 'Lotus Optique'Company Updatelow impact
Cruxal's analysis: Lotus Eye Hospital has expanded its service offerings by launching 'Lotus Optique', a new…
Read the full analysis - Lotus Eye Hospital and Institute Limited Reports Strong Q1 FY27 Financial Results with Significant Profit GrowthCompany Updatehigh impact
Cruxal's analysis: Lotus Eye Hospital and Institute Limited reported a strong performance for the quarter…
Read the full analysis - Lotus Eye Hospital Reports Strong Q1 FY27 Turnaround with 26% YoY Revenue Growth and Return to ProfitabilityBoard Meetinghigh impact
Cruxal's analysis: Lotus Eye Hospital and Institute Limited reported a robust performance for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.